227 related articles for article (PubMed ID: 32634120)
1. The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD.
Lavu S; Vaughan LE; Senum SR; Kline TL; Chapman AB; Perrone RD; Mrug M; Braun WE; Steinman TI; Rahbari-Oskoui FF; Brosnahan GM; Bae KT; Landsittel D; Chebib FT; Yu AS; Torres VE; ; Harris PC
JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32634120
[TBL] [Abstract][Full Text] [Related]
2. Age- and height-adjusted total kidney volume growth rate in autosomal dominant polycystic kidney diseases.
Higashihara E; Yamamoto K; Kaname S; Okegawa T; Tanbo M; Yamaguchi T; Shigemori K; Miyazaki I; Yokoyama K; Nutahara K
Clin Exp Nephrol; 2019 Jan; 23(1):100-111. PubMed ID: 30097754
[TBL] [Abstract][Full Text] [Related]
3. Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.
Heyer CM; Sundsbak JL; Abebe KZ; Chapman AB; Torres VE; Grantham JJ; Bae KT; Schrier RW; Perrone RD; Braun WE; Steinman TI; Mrug M; Yu AS; Brosnahan G; Hopp K; Irazabal MV; Bennett WM; Flessner MF; Moore CG; Landsittel D; Harris PC;
J Am Soc Nephrol; 2016 Sep; 27(9):2872-84. PubMed ID: 26823553
[TBL] [Abstract][Full Text] [Related]
4. Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.
Kline TL; Korfiatis P; Edwards ME; Bae KT; Yu A; Chapman AB; Mrug M; Grantham JJ; Landsittel D; Bennett WM; King BF; Harris PC; Torres VE; Erickson BJ;
Kidney Int; 2017 Nov; 92(5):1206-1216. PubMed ID: 28532709
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Mayo Imaging Classification System for Predicting Kidney Outcomes in ADPKD.
Bais T; Geertsema P; Knol MGE; van Gastel MDA; de Haas RJ; Meijer E; Gansevoort RT;
Clin J Am Soc Nephrol; 2024 May; 19(5):591-601. PubMed ID: 38407866
[TBL] [Abstract][Full Text] [Related]
6. Use of the Urine-to-Plasma Urea Ratio to Predict ADPKD Progression.
Heida JE; Gansevoort RT; Messchendorp AL; Meijer E; Casteleijn NF; Boertien WE; Zittema D;
Clin J Am Soc Nephrol; 2021 Feb; 16(2):204-212. PubMed ID: 33504546
[TBL] [Abstract][Full Text] [Related]
7. Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.
Yu ASL; Shen C; Landsittel DP; Harris PC; Torres VE; Mrug M; Bae KT; Grantham JJ; Rahbari-Oskoui FF; Flessner MF; Bennett WM; Chapman AB;
Kidney Int; 2018 Mar; 93(3):691-699. PubMed ID: 29290310
[TBL] [Abstract][Full Text] [Related]
8. Growth Pattern of Kidney Cyst Number and Volume in Autosomal Dominant Polycystic Kidney Disease.
Bae KT; Zhou W; Shen C; Landsittel DP; Wu Z; Tao C; Chapman AB; Torres VE; Yu ASL; Mrug M; Bennett WM; Harris PC;
Clin J Am Soc Nephrol; 2019 Jun; 14(6):823-833. PubMed ID: 31088850
[TBL] [Abstract][Full Text] [Related]
9. Combining genotype with height-adjusted kidney length predicts rapid progression of ADPKD.
Chen EWC; Chong J; Valluru MK; Durkie M; Simms RJ; Harris PC; Ong ACM
Nephrol Dial Transplant; 2024 May; 39(6):956-966. PubMed ID: 38224954
[TBL] [Abstract][Full Text] [Related]
10. Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials.
Irazabal MV; Rangel LJ; Bergstralh EJ; Osborn SL; Harmon AJ; Sundsbak JL; Bae KT; Chapman AB; Grantham JJ; Mrug M; Hogan MC; El-Zoghby ZM; Harris PC; Erickson BJ; King BF; Torres VE;
J Am Soc Nephrol; 2015 Jan; 26(1):160-72. PubMed ID: 24904092
[TBL] [Abstract][Full Text] [Related]
11. Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease.
Yu ASL; Shen C; Landsittel DP; Grantham JJ; Cook LT; Torres VE; Chapman AB; Bae KT; Mrug M; Harris PC; Rahbari-Oskoui FF; Shi T; Bennett WM;
Kidney Int; 2019 May; 95(5):1253-1261. PubMed ID: 30922668
[TBL] [Abstract][Full Text] [Related]
12. Patients with Protein-Truncating
Lanktree MB; Guiard E; Akbari P; Pourafkari M; Iliuta IA; Ahmed S; Haghighi A; He N; Song X; Paterson AD; Khalili K; Pei YPC
Clin J Am Soc Nephrol; 2021 Mar; 16(3):374-383. PubMed ID: 33602752
[TBL] [Abstract][Full Text] [Related]
13. Relationship of Seminal Megavesicles, Prostate Median Cysts, and Genotype in Autosomal Dominant Polycystic Kidney Disease.
Zhang W; Stephens CJ; Blumenfeld JD; Behzadi AH; Donahue S; Bobb WO; Newhouse JH; Rennert H; Zhao Y; Prince MR
J Magn Reson Imaging; 2019 Mar; 49(3):894-903. PubMed ID: 30230107
[TBL] [Abstract][Full Text] [Related]
14. PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.
Cornec-Le Gall E; Audrézet MP; Renaudineau E; Hourmant M; Charasse C; Michez E; Frouget T; Vigneau C; Dantal J; Siohan P; Longuet H; Gatault P; Ecotière L; Bridoux F; Mandart L; Hanrotel-Saliou C; Stanescu C; Depraetre P; Gie S; Massad M; Kersalé A; Séret G; Augusto JF; Saliou P; Maestri S; Chen JM; Harris PC; Férec C; Le Meur Y
Am J Kidney Dis; 2017 Oct; 70(4):476-485. PubMed ID: 28356211
[TBL] [Abstract][Full Text] [Related]
15. Multiple urinary tract infections are associated with genotype and phenotype in adult polycystic kidney disease.
Eroglu E; Kocyigit I; Cetin M; Zararsiz G; Imamoglu H; Bayramov R; Tastan S; Sipahioglu MH; Tokgoz B; Oymak O
Clin Exp Nephrol; 2019 Oct; 23(10):1188-1195. PubMed ID: 31165946
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease: Prevalence and Association with PKD2 Gene Mutations.
Kim JA; Blumenfeld JD; Chhabra S; Dutruel SP; Thimmappa ND; Bobb WO; Donahue S; Rennert HE; Tan AY; Giambrone AE; Prince MR
Radiology; 2016 Sep; 280(3):762-70. PubMed ID: 27046073
[TBL] [Abstract][Full Text] [Related]
17. Expanded Imaging Classification of Autosomal Dominant Polycystic Kidney Disease.
Bae KT; Shi T; Tao C; Yu ASL; Torres VE; Perrone RD; Chapman AB; Brosnahan G; Steinman TI; Braun WE; Srivastava A; Irazabal MV; Abebe KZ; Harris PC; Landsittel DP;
J Am Soc Nephrol; 2020 Jul; 31(7):1640-1651. PubMed ID: 32487558
[TBL] [Abstract][Full Text] [Related]
18. The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease.
Cornec-Le Gall E; Audrézet MP; Rousseau A; Hourmant M; Renaudineau E; Charasse C; Morin MP; Moal MC; Dantal J; Wehbe B; Perrichot R; Frouget T; Vigneau C; Potier J; Jousset P; Guillodo MP; Siohan P; Terki N; Sawadogo T; Legrand D; Menoyo-Calonge V; Benarbia S; Besnier D; Longuet H; Férec C; Le Meur Y
J Am Soc Nephrol; 2016 Mar; 27(3):942-51. PubMed ID: 26150605
[TBL] [Abstract][Full Text] [Related]
19. Rapid Progression of Autosomal Dominant Polycystic Kidney Disease: Urinary Biomarkers as Predictors.
Messchendorp AL; Meijer E; Visser FW; Engels GE; Kappert P; Losekoot M; Peters DJM; Gansevoort RT;
Am J Nephrol; 2019; 50(5):375-385. PubMed ID: 31600749
[TBL] [Abstract][Full Text] [Related]
20. Effect of tolvaptan on renal involvement in patients with autosomal dominant polycystic kidney disease according to different gene mutations.
Moriyama T; Nakayama Y; Soejima M; Yokota Y; Ota K; Ito S; Kodama G; Nakamura N; Kurokawa Y; Yano J; Ueda U; Takamiya Y; Kaida Y; Hazama T; Shibata R; Koda Y; Fukami K
Clin Exp Nephrol; 2021 Mar; 25(3):251-260. PubMed ID: 33141305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
